Inhibikase Therapeutics logo

Inhibikase Therapeutics

IKT | NASDAQ
Chart Builder DCF Calculator
$1.45
-$0.07 (-4.61%)
At close: Nov 16, 2026, 4:00 PM ET
$1.45
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-4.61%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
35.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #645/1021 (Top 63%)

Key Statistics

Market Data

Market Cap $285.56M
1D Range
1.45 1.57
52W Range
1.41 2.52

Valuation (TTM)

PE -3.22
PB 1.51
EV/EBITDA -1.33

Valuation (NTM)

Forward PE N/A
Forward PEG 0.23
Price Target $5.00
Loading financial charts...

Profile

Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics to modify the course of cardiopulmonary diseases, with a primary focus on pulmonary arteria...

Sector Healthcare
Industry Biotechnology
Employees 35
IPO Date Dec 23, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$5.00
Upside
+244.83%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.